Evidence map›Paper›PMID 28869608›Full record

ArticleNature structural & molecular biology2017

CNPY2 is a key initiator of the PERK-CHOP pathway of the unfolded protein response.

Feng Hong, Bei Liu, Bill X Wu, Jordan Morreall, Brady Roth, Christopher Davies, Shaoli Sun, J Alan Diehl, Zihai Li

Open access · greenAbstract read
In one paragraph

Article in Nature structural & molecular biology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed, 1 pooled it
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 1 synthesis or guideline pooled it, 63 citations in OpenAlex.

  1. Pooled it
  2. Cnpy1 is a candidate endoplasmic reticulum chaperone of vomeronasal type 2 GPCRs.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. CNPY2 drives DSS-induced colitis via the macrophage-ROS axis.Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 2025
    Article
  9. Article
  10. Inhalable Hsa-miR-30a-3p Liposomes Attenuate Pulmonary Fibrosis.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Article
  11. Article
  12. Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 2 countries.

Feng HongDepartment of Microbiology &Immunology, Medical University of South Carolina, Charleston, South Carolina, USA.
Bei LiuDepartment of Microbiology &Immunology, Medical University of South Carolina, Charleston, South Carolina, USA.
Bill X WuDepartment of Microbiology &Immunology, Medical University of South Carolina, Charleston, South Carolina, USA.
Jordan MorreallDepartment of Microbiology &Immunology, Medical University of South Carolina, Charleston, South Carolina, USA.
Brady RothDepartment of Biochemistry and Molecular Biology, Medical University of South Carolina, Charleston, South Carolina, USA.ORCID http://orcid.org/0000-0001-7559-7671
Christopher DaviesDepartment of Biochemistry and Molecular Biology, Medical University of South Carolina, Charleston, South Carolina, USA.
Shaoli SunDepartment of Pathology and Laboratory Medicine, Medical University of South Carolina, Charleston, South Carolina, USA.
J Alan DiehlHollings Cancer Center, Medical University of South Carolina, Charleston, South Carolina, USA.
Zihai LiDepartment of Microbiology &Immunology, Medical University of South Carolina, Charleston, South Carolina, USA.
Medical University of South Carolina · US

Funding

TRANSLATIONAL CONTROL IN ADAPTATION TO HYPOXIAP01CA104838 · NCI · UNIVERSITY OF PENNSYLVANIA · PI DIEHL, JOHN ALAN · 2004 to 2018
$17.6M
UPR, interferon signaling and tumorigenesisP01CA165997 · NCI · UNIVERSITY OF PENNSYLVANIA · PI KOUMENIS, CONSTANTINOS · 2013 to 2023
$10.9M
Project 3: Structural Basis for grp94 Drug Development and Chaperone FunctionP01CA186866 · NCI · OHIO STATE UNIVERSITY · PI LI, ZIHAI · 2015 to 2019
$6.7M
Roles and Mechanisms of gp96 in Chaperoning Innate ImmunityR01AI070603 · NIAID · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI LI, ZIHAI · 2007 to 2016
$3.8M
Extrinsic and intrinsic factors regulating commensal-specific T helper-17 cellsU01AI125859 · NIAID · OHIO STATE UNIVERSITY · PI LIU, BEI · 2016 to 2020
$2.5M
Thrombocytes in Cancer ImmunityR01CA188419 · NCI · OHIO STATE UNIVERSITY · PI LI, ZIHAI · 2015 to 2019
$1.9M
Mechanism of gp96/grp94 in regulating plasma cells and myelomaR01CA193939 · NCI · OHIO STATE UNIVERSITY · PI LIU, BEI · 2016 to 2020
$1.7M
Novel mechanisms of UPR sensing and nonalcoholic fatty liver diseaseR01DK105033 · NIDDK · OHIO STATE UNIVERSITY · PI LI, ZIHAI · 2016 to 2020
$1.7M
Integration of inflammation and cancer by molecular chaperoneR01CA213290 · NCI · OHIO STATE UNIVERSITY · PI LI, ZIHAI · 2017 to 2021
$860k
NCI NIH HHS P01 CA104838NCI NIH HHS P01 CA165997NCI NIH HHS P01 CA186866NCI NIH HHS R01 CA188419NCI NIH HHS R01 CA193939NCI NIH HHS R01 CA213290NIAID NIH HHS R01 AI070603NIAID NIH HHS U01 AI125859NIDDK NIH HHS R01 DK105033
6 · The paper itself

Abstract

The unfolded protein response (UPR) in the endoplasmic reticulum (ER) is a highly conserved protein-quality-control mechanism critical for cells to make survival-or-death decisions under ER-stress conditions. However, how UPR sensors are activated remains unclear. Here, we report that ER luminal protein canopy homolog 2 (CNPY2) is released from grp78 upon ER stress. Free CNPY2 then engages protein kinase R-like ER kinase (PERK) to induce expression of the transcription factor C/EBP homologous protein (CHOP), thereby initiating the UPR. Indeed, deletion of CNPY2 blocked the PERK-CHOP pathway and protected mice from UPR-induced liver damage and steatosis. Additionally, CNPY2 is transcriptionally upregulated by CHOP in a forward-feed loop to further enhance UPR signaling. These findings demonstrate the critical roles of CNPY2 in ER stress and suggest that CNPY2 is a potential new therapeutic target for UPR-related diseases such as metabolic disorders, inflammation and cancer.

Indexed as

Unfolded Protein ResponseAnimalsCell LineeIF-2 KinaseEndoplasmic Reticulum Chaperone BiPGene DeletionGene Expression RegulationHumansIntracellular Signaling Peptides and ProteinsMembrane ProteinsMice, Inbred C57BLMice, KnockoutTranscription Factor CHOPCanopy 2 protein, mouseDdit3 protein, mouseeIF-2 KinaseEndoplasmic Reticulum Chaperone BiPHSPA5 protein, humanHspa5 protein, mouseIntracellular Signaling Peptides and ProteinsMembrane ProteinsTranscription Factor CHOP

Identifiers

PMID28869608
PMCPMC6102046
OpenAlexW2753585792

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.